Ours and other recent data support a model in which CD11c+ ATM subtypes localize to CLS, accumulating in response to changes in local lipid concentrations and obesity-related chemokines, becoming lipid-laden and protecting adipose tissue from lipotoxicity (2, 28, 38–40). The gene discussed is ITGAX; the disease is obesity disorder.